scispace - formally typeset
Search or ask a question
Institution

World Health Organization

GovernmentIslamabad, Pakistan
About: World Health Organization is a government organization based out in Islamabad, Pakistan. It is known for research contribution in the topics: Population & Public health. The organization has 13330 authors who have published 22232 publications receiving 1322023 citations. The organization is also known as: World Health Organisation & WHO.


Papers
More filters
Journal ArticleDOI
TL;DR: While there was some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar, and K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia.
Abstract: The emergence of artemisinin-resistant Plasmodium falciparum in Southeast Asia threatens malaria treatment efficacy. Mutations in a kelch protein encoded on P. falciparum chromosome 13 (K13) have been associated with resistance in vitro and in field samples from Cambodia.P. falciparum infections from artesunate efficacy trials in Bangladesh, Cambodia, Laos, Myanmar, and Vietnam were genotyped at 33 716 genome-wide single-nucleotide polymorphisms (SNPs). Linear mixed models were used to test associations between parasite genotypes and parasite clearance half-lives following artesunate treatment. K13 mutations were tested for association with artemisinin resistance, and extended haplotypes on chromosome 13 were examined to determine whether mutations arose focally and spread or whether they emerged independently.The presence of nonreference K13 alleles was associated with prolonged parasite clearance half-life (P = 1.97 × 10(-12)). Parasites with a mutation in any of the K13 kelch domains displayed longer parasite clearance half-lives than parasites with wild-type alleles. Haplotype analysis revealed both population-specific emergence of mutations and independent emergence of the same mutation in different geographic areas.K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia. While we found some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar.

390 citations

Journal ArticleDOI
TL;DR: WHO with the support of PDVI initiated a program to coordinate the procedures used for the plaque-reduction neutralization test (PRNT), the most common assay used to measure neutralizing antibody.
Abstract: Through the Advisory Committee on Dengue and other Flavivirus Vaccines, the World Health Organization (WHO) has had a long-standing commitment to facilitate and to guide research and development of...

386 citations

Journal ArticleDOI
TL;DR: A 10% reduction in ACE prevalence could equate to annual savings of 3 million DALYs or $105 billion and relieve pressures on health-care systems, according to the findings of this systematic review and meta-analysis.
Abstract: Summary Background An increasing number of studies are identifying associations between adverse childhood experiences (ACEs) and ill health throughout the life course. We aimed to calculate the proportions of major risk factors for and causes of ill health that are attributable to one or multiple types of ACE and the associated financial costs. Methods In this systematic review and meta-analysis, we searched for studies in which risk data in individuals with ACEs were compared with these data in those without ACEs. We searched six electronic databases (MEDLINE, CINAHL, PsycINFO, Applied Social Sciences Index and Abstracts, Criminal Justice Databases, and the Education Resources Information Center) for quantitative studies published between Jan 1, 1990, and July 11, 2018, that reported risks of health-related behaviours and causes of ill health in adults that were associated with cumulative measures of ACEs (ie, number of ACEs). We included studies in adults in populations that did not have a high risk of ACEs, that had sample sizes of at least 1000 people, and that provided ACE prevalence data. We calculated the pooled RR for risk factors (harmful alcohol use, illicit drug use, smoking, and obesity) and causes of ill health (cancer, diabetes, cardiovascular disease, respiratory disease, anxiety, and depression) associated with ACEs. RRs were used to estimate the population-attributable fractions (PAFs) of risk attributable to ACEs and the disability-adjusted life-years (DALYs) and financial costs associated with ACEs. This study was prospectively registered in PROSPERO (CRD42018090356). Findings Of 4387 unique articles found following our initial search, after review of the titles (and abstracts, when the title was relevant), we assessed 880 (20%) full-text articles. We considered 221 (25%) full-text articles for inclusion, of which 23 (10%) articles met all selection criteria for our meta-analysis. We found a pooled prevalence of 23·5% of individuals (95% CI 18·7–28·5) with one ACE and 18·7% (14·7–23·2) with two or more ACEs in Europe (from ten studies) and of 23·4% of individuals (22·0–24·8) with one ACE and 35·0% (31·6–38·4) with two or more ACEs in north America (from nine studies). Illicit drug use had the highest PAFs associated with ACEs of all the risk factors assessed in both regions (34·1% in Europe; 41·1% in north America). In both regions, PAFs of causes of ill health were highest for mental illness outcomes: ACEs were attributed to about 30% of cases of anxiety and 40% of cases of depression in north America and more than a quarter of both conditions in Europe. Costs of cardiovascular disease attributable to ACEs were substantially higher than for most other causes of ill health because of higher DALYs for this condition. Total annual costs attributable to ACEs were estimated to be US$581 billion in Europe and $748 billion in north America. More than 75% of these costs arose in individuals with two or more ACEs. Interpretation Millions of adults across Europe and north America live with a legacy of ACEs. Our findings suggest that a 10% reduction in ACE prevalence could equate to annual savings of 3 million DALYs or $105 billion. Programmes to prevent ACEs and moderate their effects are available. Rebalancing expenditure towards ensuring safe and nurturing childhoods would be economically beneficial and relieve pressures on health-care systems. Funding World Health Organization Regional Office for Europe.

386 citations

Journal ArticleDOI
TL;DR: The conclusion is that the duration of the asylum procedure is an important risk factor for psychiatric problems and politicians and mental health workers should take note of this finding.
Abstract: Clinically, a long asylum procedure seems to be associated with psychiatric disorders. However, data on this issue are lacking. In a national community-based study, using random sampling, we compared two groups of Iraqi asylum seekers, who had resided less than 6 months (N = 143) and more than 2 years (N= 151), respectively, in The Netherlands. Respondents were interviewed with fully structured, culturally validated, translated questionnaires. Psychiatric (DSM-IV) disorders were measured with the Composite International Diagnostic Interview 2.1 and evaluated in relation with premigration and postmigration adverse life events. Overall prevalence of psychiatric disorders was 42% in the first group and 66.2% in the second. The prevalence rates of anxiety, depressive, and somatoform disorders were significantly higher in the second group. Posttraumatic stress disorder was high in both groups but did not differ (p > .05). On logistic regression of all relevant risk factors, a long asylum procedure showed an odds ratio of 2.16 (confidence interval = 1.15-4.08) for psychopathology. The conclusion is that, indeed, the duration of the asylum procedure is an important risk factor for psychiatric problems. Both politicians and mental health workers should take note of this finding.

385 citations

Journal ArticleDOI
Jean Thierry Aubin1, Saliha Azebi1, Amanda Balish1, Jill Banks1, Niranjan Bhat1, Rick A. Bright1, Ian Brown1, Philippe Buchy1, Ana Maria Burguiere1, Hua Ian Chen1, Peter K.C. Cheng1, Nancy J. Cox1, Alice Crosier1, Aaron Curns1, Frédérique Cuvelier1, Guohua Deng1, Julia Desheva1, Stéphanie Desvaux1, Nguyen Hong Diep1, Ruben O. Donis2, Ruben O. Donis1, A. R. Douglas1, Scott F. Dowell1, Nguyen Tien Dung1, Lindsay Edwards1, Keiji Fukuda1, Rebecca Garten1, Elena A. Govorkova1, Victoria Gregory1, Alan W. Hampson1, Nguyen Thi Hong Hanh1, Scott A. Harper1, A. Hay1, Erich Hoffmann1, Diane J. Hulse1, Masaki Imai1, Shigeyuki Itamura1, Samadhan Jadhao1, Patricia Jeannin1, Chun Kang1, Jackie Katz1, Jae Hong Kim1, Alexander Klimov1, Yong Kuk Kwon1, Chang-Won Lee1, Phuong Song Lien1, Yanbing Li1, Wilina Lim1, Yi Pu Lin1, Stephen Lindstom1, La Morris Loftin1, Jan Mabry1, Le Quynh Mai1, Taronna R. Maines1, Jean Claude Manuguerra1, Masaji Mase1, Yumi Matsuoka1, Margaret McCarron1, Marie-Jo Medina1, Doan Nguyen1, Ai Ninomiya1, Masatsugu Obuchi1, Takato Odagiri1, Malik Peiris1, Michael L. Perdue1, Jean Marc Reynes1, James Robertson1, Claudine Rousseaux1, Takehiko Saito1, Somchai Sangkitporn1, Michael W. Shaw1, James Mark Simmerman1, Marek J. Slomka1, Catherine K. Smith1, San Sorn1, Erica Spackman1, Klaus Stöhr1, David L. Suarez1, Haan Woo Sung1, David E. Swayne1, Maryse Tardy-Panit1, Masato Tashiro1, Pranee Thawatsupha1, Terrence M. Tumpey1, Timothy M. Uyeki1, Phan Van Tu1, Sylvie van der Werf1, Sirenda Vong1, Richard J. Webby1, Robert G. Webster1, John Wood1, Xiyan Xu1, Guan Yi1, Wenging Zhang1 
TL;DR: Human infections were from a virus clade undergoing antigenic drift that showed resistance to adamantanes but sensitivity to neuraminidase inhibitors.
Abstract: Human infections were from a virus clade undergoing antigenic drift that showed resistance to adamantanes but sensitivity to neuraminidase inhibitors.

384 citations


Authors

Showing all 13385 results

NameH-indexPapersCitations
Christopher J L Murray209754310329
Michael Marmot1931147170338
Didier Raoult1733267153016
Alan D. Lopez172863259291
Zulfiqar A Bhutta1651231169329
Simon I. Hay165557153307
Robert G. Webster15884390776
Ali H. Mokdad156634160599
Matthias Egger152901184176
Paolo Boffetta148145593876
Jean Bousquet145128896769
Igor Rudan142658103659
Holger J. Schünemann141810113169
Richard M. Myers134496137791
Majid Ezzati133443137171
Network Information
Related Institutions (5)
Centers for Disease Control and Prevention
82.5K papers, 4.4M citations

92% related

Public Health Research Institute
8.1K papers, 276.9K citations

91% related

Liverpool School of Tropical Medicine
8.6K papers, 325K citations

90% related

Norwegian Institute of Public Health
8.1K papers, 362.8K citations

90% related

University of London
88K papers, 4M citations

89% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202319
202279
20211,792
20201,612
20191,402
20181,360